Showing results (91-100 of 146) with videos related to
Sort By:
Pageof 15
Clinical and Experimental Rheumatology|July 10, 2002
Urinary soluble VCAM-1 in systemic lupus erythematosus: a clinical marker for monitoring disease activity and damageY Molad, E Miroshnik, J Sulkes, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 22, 2001
Sporotrichoid lymphangitis due to group A StreptococcusJ Bishara, Y Cohen, B Gabay, et al.Archives of Internal Medicine|June 1, 1983
Nonbacterial thrombotic endocarditis in a male homosexual with Kaposi's sarcomaI Garcia, V Fainstein, A Rios, et al.Cancer|July 15, 1987
Imipenem/cilastatin therapy of infections in cancer patientsG P Bodey, L Elting, P Jones, et al.The American Journal of Medicine|October 30, 1984
Systemic candidiasis in cancer patientsA W Maksymiuk, S Thongprasert, R Hopfer, et al.The Journal of Infectious Diseases|February 1, 1994
A randomized double-blind trial of vancomycin versus teicoplanin for the treatment of gram-positive bacteremia in patients with cancerK V Rolston, H Nguyen, G Amos, et al.Antimicrobial Agents and Chemotherapy|January 1, 1987
Amphotericin B or ketoconazole therapy of fungal infections in neutropenic cancer patientsV Fainstein, G P Bodey, L Elting, et al.The Journal of Antimicrobial Chemotherapy|December 1, 1986
Imipenem/cilastatin as secondary therapy for infections in cancer patientsG P Bodey, K Rolston, P Jones, et al.Archives of Internal Medicine|July 1, 1986
Hypoprothrombinemia in patients with cancer receiving cefoperazone and mezlocillinP G Jones, S V Strother, K V Rolston, et al.Medicine|March 1, 1988
The emerging role of Fusarium infections in patients with cancerE Anaissie, H Kantarjian, J Ro, et al.Pageof 15